News & Updates
Filter by Specialty:

Cilostazol, ticagrelor more cost-effective than standard therapy for acute ischaemic stroke
Use of CYP2C19 genotype-guided antiplatelet therapy with cilostazol or ticagrelor as a substitute to clopidogrel is more cost-effective than conventional antiplatelet therapy for patients with acute minor ischaemic stroke and high-risk transient ischaemic attack, suggests a China study.
Cilostazol, ticagrelor more cost-effective than standard therapy for acute ischaemic stroke
29 Feb 2024
Drinking coffee may help prevent migraine
Coffee intake appears to have a causal relationship with migraine, as shown by the results of a Mendelian randomization (MR) study. This finding suggests that drinking coffee will either trigger or prevent migraine.
Drinking coffee may help prevent migraine
26 Feb 2024
Reteplase a good alternative to alteplase in acute ischaemic stroke
Treatment with reteplase appears more effective than alteplase in patients with acute ischaemic stroke (AIS) who have been treated within 4.5 hours of symptom onset, according to the results of RAISE, a phase III multicentre, open-label, randomized controlled, noninferiority trial.
Reteplase a good alternative to alteplase in acute ischaemic stroke
20 Feb 2024
Earlier anticoagulation reversal tied to improved survival in ICH patients
In anticoagulation-associated intracerebral haemorrhage (ICH), earlier administration of reversal treatments is associated with reduced in-hospital mortality or discharge to hospice, according to data presented at ISC 2024.